An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants

Completed · Phase 1

Conditions studied: Cardiac Failure, Myocardial Failure

In brief

The purpose of this study is to investigate the experimental medication BMS-986224 in participants with varying levels of renal function.

Key facts

Study ID

NCT03634969

Run by

Bristol-Myers Squibb

People needed

50

Starts

2018-08-14

Expected to finish

2019-04-30

Last updated by the study team

2020-02-25

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI ≥18 and ≤ 35kg/m2
• Systolic blood pressure >100 mmHg

You may not qualify if…

• Women of childbearing potential or women who are currently pregnant
• Clinically relevant abnormal medical history, abnormal findings on physical examination, vital signs, ECG, or laboratory tests at screening that the investigator judges as likely to interfere with the objectives of the trial or the safety of the volunteer
• Current or recent (within 3 months of study treatment administration) gastrointestinal disease that could affect absorption
• Other protocol defined inclusion/exclusion criteria could apply

Where it is running

• Clinical Pharmacology of Miami — Miami, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States
• Prism Research — Saint Paul, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.